April 14, 2021
Business News

Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference


BOSTON–()–Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate in the virtual H.C. Wainwright Global Life Sciences Conference. The fireside chat will be made available for on-demand listening beginning Tuesday, March 9, 2021 at 7:00 a.m. EST.

The webcast of the fireside chat will be available on the “Media” section of the Company’s website at www.verastem.com under “Events & Presentations”.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of…



Click here to view the original article.

Related Posts

You might also like ...

Spark NZ Selects Calabrio as Part of Unified Front Line Initiative
AlixPartners Disruption Index Reveals That Business Leaders Don’t Consider COVID-19 to Be the Most Disruptive Force Impacting Their Organization
Germany’s Supreme Court Rules in Solvay’s Favor on Patent Case With Neo